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Norovirus  
GII.4/Sydney/2012 
in Italy,  
Winter 2012–2013
To the Editor: Noroviruses 
(NoVs) are the major cause of acute 
gastroenteritis in children and adults; 
they are responsible for sporadic cases 
and outbreaks of gastroenteritis in var-
ious epidemiologic settings. NoVs can 
be classified genetically into at least 5 
genogroups, GI to GV (1). Although 
>30 genotypes within genogroups GI, 
GII, and GIV can infect humans (2), 
a single genotype, GII.4, has been as-
sociated with most NoV-related out-
breaks and sporadic cases of gastroen-
teritis worldwide (3).
GII.4 NoV strains continuously 
undergo genetic/antigenic diversifica-
tion and periodically generate novel 
strains through accumulation of punc-
tate mutations or recombination. New 
GII.4 variants emerge every 2–3 years 
(4). Increased incidence of NoV-relat-
ed illness and/or outbreaks in various 
countries in late 2012 has been related 
to the emergence of a novel GII.4 vari-
ant, Sydney 2012. This variant was 
first identified in March 2012 in Aus-
tralia (5).
The Italian Study Group for En-
teric Viruses (ISGEV; http://isgev.net) 
monitors the epidemiology of enteric 
viruses in children through hospital-
based surveillance (6–8). NoVs are 
monitored and characterized by multi-
target analysis in the diagnostic regions 
A (open reading frame 1, polymerase) 
and C (open reading frame 2, capsid) of 
the NoV genome (9) and interrogation 
of the Norovirus Typing Tool database 
(www.rivm.nl/mpf/norovirus/typing-
tool). During November 2011–March 
2012, the prevalence of sporadic NoV 
infections detected (in samples from 
newborns, infants, and children up to 5 
years of age) by real-time reverse tran-
scription PCR was 22.2% (121/545). 
A subset (≈50%) of the NoV-positive 
samples representative of the whole 
winter period was selected for sequence 
analysis, and 48 were successfully 
characterized in region A and region C. 
Among these 48 NoV strains, 
20 (41.7%) were characterized as the 
variant GII.4 New Orleans 2009, a 
smaller number, 6 (12.5%), displayed 
a New Orleans 2009 polymerase (pol) 
but 2 distinct GII.4 capsid sequences, 
which were not typeable in the Noro-
virus Typing Tool database, and only 2 
(4.2%) GII.4 strains of the variant Den 
Haag 2006b were detected. Moreover, 
4 sporadic cases in November 2011 and 
January 2012 and a small outbreak in 
February 2012 were related to a GII.
Pe_GII.4 recombinant strain. After the 
set of sequences of GII.4 variants from 
the Norovirus Typing Tool database 
was updated (access to the updated 
database: April 11, 2013), 5 (10.4%) 
GII.Pe_GII.4 recombinant strains were 
characterized as variant Sydney 2012.
From April through October 2012, 
a total of 56 (7.6%) NoV-positive sam-
ples were detected from 737 analyzed 
samples, of which 34 (60.7%) NoV-pos-
itive samples could be sequenced. Of 
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these, 41.2% were characterized as GII.3 
(mostly with a GII.Pb pol), 26.5% as GII.
Pg_GII.1, and 17.6% as GII.4 variants. 
From spring to fall 2012, the vari-
ant New Orleans 2009 became the 
predominant GII.4 strain, and the vari-
ant Sydney 2012 strain apparently 
disappeared. 
During November–December 
2012 and January 2013, ISGEV de-
tected NoV infection in 90 (28.9%) of 
311 children hospitalized for gastroen-
teritis. This finding is comparable to a 
prevalence of 25.2% in the same period 
(November–January) of the 2011–12 
winter season. A representative subset 
of 45 samples was randomly selected 
for sequencing, and 26 (74.3%) of 35 
fully typed strains were characterized 
as GII.4 Sydney 2012, which suggested 
that the new NoV variant had become 
the predominant strain in Italy. 
Our surveillance seem to mirror 
observations of a report from Denmark 
that documented the onset and circula-
tion at low prevalence of the variant 
GII.4 Sydney 2012 at the beginning 
of 2012 with a marked increase in the 
prevalence only by the end of 2012 
(10). Our surveillance detected the 
emergence of this variant in Italy at 
the end of 2011 and provided us with 
one of the earliest strains of the variant 
GII.4 Sydney 2012. This novel vari-
ant has a common ancestor with the 
NoV GII.4 variants Apeldoorn 2008 
and New Orleans 2009 and has sev-
eral amino acid changes on the main 
epitope in the capsid P2 domain (10). 
Sequence analysis of these early 
strains of the GII.4 variant Sydney 
2012 could help clarify the mecha-
nisms driving its global emergence 
and spread. Continued surveillance 
for NoV infections through ISGEV 
and additional data on clinical and 
epidemiologic features will enable 
further assessment of the public health 
implications of the new variant GII.4 
Sydney 2012 in Italy.
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Group C  
Betacoronavirus  
in Bat Guano  
Fertilizer, Thailand
To the Editor: Bats play a criti-
cal role in the transmission and origin 
of zoonotic diseases, primarily viral 
zoonoses associated with high case-
fatality rates, including those caused 
by Nipah virus (NiV) and severe acute 
respiratory syndrome (SARS)–like 
coronavirus (CoV) infections (1). Re-
cently, the World Health Organization 
(WHO) reported 44 confirmed cases 
of human infection with Middle East 
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